EXO FORTIFY Revitalizing Hair & Scalp Treatment

Route: Topical scalp application.

Part the hair to expose the scalp in targeted areas. Apply the treatment directly to the scalp using the dropper or applicator provided. Gently massage into the scalp with fingertips for 1–2 minutes to promote absorption and local microcirculation. Do not rinse out; allow to absorb. For enhanced penetration, application following microneedling or dermarolling of the scalp (as directed by the clinician) is recommended. Wash hands thoroughly after application. Avoid contact with eyes.

Application protocol is prescriber-directed. Typical patterns for scalp exosome treatments:

• Apply once or twice daily to affected scalp areas, or as directed by the prescribing clinician.
• If used post-scalp microneedling: apply immediately after the procedure and at prescribed frequency thereafter.
• Minimum 3–6 months of consistent use before a formal hair density and follicular assessment is recommended, as hair cycling response requires time.

Extracellular vesicles in EXO FORTIFY target follicular biology through their diverse bioactive cargo:

• Dermal papilla stimulation: VEGF and FGF growth factors within vesicles stimulate dermal papilla cell proliferation and survival, critical for maintaining the follicle's ability to drive anagen growth.
• Wnt/β-catenin pathway activation: miRNA cargo and signaling proteins modulate Wnt pathway components in follicular stem cells, promoting their transition from quiescence (telogen) into the growth (anagen) phase.
• Anti-DHT inflammatory signaling: Anti-inflammatory miRNAs reduce IL-6 and TNF-α levels in the scalp microenvironment, attenuating inflammation-driven follicular miniaturization that parallels DHT signaling in androgenetic alopecia.
• Angiogenesis: VEGF within vesicle cargo promotes new capillary formation around follicular bulbs, increasing nutrient and oxygen delivery to metabolically active growing follicles.

Clinical Context: EXO FORTIFY is intended for prescriber-directed use in hair restoration protocols for androgenetic alopecia, post-partum hair loss, alopecia areata (in remission), or diffuse hair thinning. It is used as a complementary agent alongside evidence-based pharmacological treatments (minoxidil, finasteride, spironolactone) and procedural interventions (PRP, scalp microneedling, low-level laser therapy). Exosome-based scalp therapy evidence is derived from early-phase clinical studies and mechanistic preclinical data.

Monitoring Considerations:

• Baseline trichoscopy and standardized scalp photography prior to initiating treatment.
• Assess follicular density, hair caliber, and telogen-to-anagen ratio at 3-month intervals using trichoscopy or densitometry.
• Coordinate with any concurrent systemic or procedural hair restoration treatments.

Contraindications:

• Known hypersensitivity to any component of the preparation.
• Active scalp infection (fungal, bacterial) or open scalp wounds — defer treatment until resolved.
• Scarring alopecia in active inflammatory phase — exosome therapy does not address fibrotic follicular destruction and should not be applied to sites of active cicatricial alopecia without specialist guidance.

Warnings & Precautions:

• For topical scalp use only. Avoid ocular and facial mucous membrane contact.
• Clinical evidence for exosome-based hair restoration is still emerging; prescribers should set appropriate patient expectations and monitor outcomes systematically.

Drug Interactions:

• No established pharmacokinetic interactions. Coordinate application timing relative to any topical minoxidil preparations used concomitantly, as prescribed.

Common Side Effects: Generally well tolerated. Mild transient scalp irritation, tingling, or pruritus — particularly following microneedling-assisted delivery.

Refrigerate at 2–8°C (36–46°F) to preserve vesicle bioactivity. Do not freeze. Protect from light. Bring to room temperature before scalp application if instructed. Keep out of reach of children. Use before the BUD printed on the Genesis Compounding label.

How is this different from PRP for hair loss?

Platelet-rich plasma (PRP) delivers growth factors derived from your own blood platelets. EXO FORTIFY uses exosomes — purified extracellular vesicles — which provide a more standardized and concentrated cargo of growth factors and miRNAs without the variability of autologous biological preparations. Both are used in hair restoration; they can be complementary when prescribed together.

Can I use this with minoxidil?

Yes — EXO FORTIFY is typically used as an adjunct alongside first-line pharmacological treatments. Your prescriber will specify the application schedule and whether the two preparations should be applied at the same time or separately.

Is this FDA-approved for hair loss?

No. This is a prescription-only 503A compounded preparation made by Genesis Compounding. Exosome preparations are not FDA-approved drug products. They are used as part of individualized prescriber-directed hair restoration protocols.

Why does it take 3–6 months to see results?

Hair follicle cycling occurs in phases (anagen, catagen, telogen) over months. Regenerative therapies must positively influence this cycle, which naturally takes time. Trichoscopy at baseline and follow-up visits helps document measurable progress.

Should I combine scalp microneedling with this treatment?

Scalp microneedling significantly enhances penetration of topical preparations into the dermal papilla region. Many clinicians combine EXO FORTIFY application immediately post-microneedling as part of an intensive hair restoration protocol. Your prescriber will advise on whether this combination is appropriate for your situation.